Bloomberg
AstraZeneca Vaccine: Key Facts Around Safety, Risks
Mar.17 -- As several European Union nations suspend AstraZeneca Plc's Covid-19 vaccine, Oksana Pyzig, virologist at University College London, breaks down the data around safety and risks. She speaks on Bloomberg Television.
Bloomberg
U.K. 'Reckless' in Easing Covid Curbs: Johns Hopkins' Beyrer
Johns Hopkins Bloomberg School of Public Health Professor Chris Beyrer discusses the easing of Covid curbs in the U.K. and continued omicron risk in the U.S. The Bloomberg School of Public Health is supported by Michael R. Bloomberg,...
Curated Video
Could Next COVID Wave Mean More Vaccine Shots?
It's been at least five months since many Americans received their last vaccine shot, and studies show immunity can decline after that time.
Curated Video
Global Death Toll Surpasses 6 Million For Pandemic Now In 3rd Year
It's the latest reminder of the unrelenting nature of the pandemic even as people are shedding masks, travel is resuming and businesses are reopening.
Bloomberg
Covid-19 Absolutely Not Endemic: Johns Hopkins' Hansoti
Johns Hopkins University Associate Professor of Emergency Medicine Bhakti Hansoti discusses the evolution of Covid-19 and global surges of the virus. The Bloomberg School of Public Health is supported by Michael R. Bloomberg, founder and...
AFP News Agency
CLEAN : Singaporeans support move to stop paying medical bills for unvaccinated
Singaporeans voice support for the government's announcement last week that it would stop paying the coronavirus medical bills of those who are unvaccinated by choice (Footage by AFPTV via Getty Images)
Bloomberg
China Locks Down Shenzhen as Covid Cases Jump
Virus cases are spiking across China, with the 17.5 million residents of Shenzhen put into a lockdown that's due to last until Mar. 20. Bloomberg's Emma O'Brien reports on "Bloomberg Daybreak: Australia."
Bloomberg
China Reports Over 5,000 Covid Cases as More Cities Locked Down
China saw more than 5,000 new Covid-19 infections for the first time since the early days of the pandemic, as outbreaks of the highly contagious omicron variant prompt officials to lock down more cities and impose restrictions....
Bloomberg
Johns Hopkins' Pekosz Sees Signs of Delta Peaking in U.S.
Aug.23 -- Johns Hopkins Bloomberg School of Public Health Professor and Virologist Andrew Pekosz discusses the trajectory of U.S. delta variant infections on "Bloomberg Surveillance: Early Edition." The Bloomberg School of Public Health...
Bloomberg
New U.K Omicron Cases Double
Prime Minister Boris Johnson is warning the U.K. is facing a "tidal wave of infections" and set an end-of-year deadline for boosters after the number of new cases doubled on Sunday. Bloomberg's Emma O'Brien reports on "Bloomberg...
Bloomberg
Transmission Data Is Key for New Covid Variant: Epidemiologist Hodcroft
University of Bern Molecular Epidemiologist Emma Hodcroft discusses the development of Covid-19 variants as a new one is identified in South Africa. She speaks on "Bloomberg Surveillance Early Edition."
Bloomberg
Boosters Provide 70-75% Omicron Protection in U.K. Study
A U.K. study has shown Covid-19 vaccine boosters improve protection to as much as 75% against the omicron variant. Bloomberg Intelligence's Sam Fazeli has more.
Curated Video
President Biden To Require Vaccines For Nursing Home Staff
Hundreds of thousands of nursing home workers are not vaccinated, according to federal data.
Bloomberg
Ausbil CIO Xiradis on Australia's Growth Outlook Amid Covid
Paul Xiradis, executive chairman, chief investment officer and head of equities at Ausbil Investment Management, looks at how the Covid-19 pandemic is affecting the Australian economy and its financial markets. He also discusses the...
Bloomberg
ANU's Senanayake: Never Say Never with COVID-19
Sanjaya Senanayake, Australian National University Medical School associate professor, discusses the latest on the omicron variant and the measures being taken to mitigate its global spread. He speaks with Shery Ahn and Paul Allen on...
Bloomberg
FDA Clears Moderna, J&J Boosters and Backs Vaccine Mixing
The U.S. Food and Drug Administration said Moderna Inc. vaccine recipients 65 and over can receive a third shot, and Johnson & Johnson recipients 18 and older are eligible for a booster shot at least two months after receiving their...
Bloomberg
Pfizer CEO Projects $29 Billion in Sales of Covid Vaccine
Pfizer Inc. raised its full-year forecast on the strength of Covid-19 vaccine sales and provided its first glimpse at potential gains for 2022, projecting $29 billion in sales from the shot it developed with BioNTech SE. CEO Albert...
Bloomberg
Star Alliance CEO: Recovery Is On The Way
Jeffrey Goh, CEO of the world's largest global airline alliance, Star Alliance, says airlines should prepare for the recovery in the aviation industry. Star Alliance is the 26-airline group whose members include Singapore Airlines,...
Bloomberg
Johns Hopkins: New Variants Don't Compare to Omicron
Johns Hopkins Bloomberg School of Public Health Professor and Virologist Andrew Pekosz discusses the path of Covid-19 infections and the emergence of new variants of the virus on "Bloomberg Surveillance." The Bloomberg School of Public...
Bloomberg
Not Everyone Needs a Booster Shot, Says JHU's Nuzzo
Aug.19 -- Johns Hopkins Center for Health Security Senior Scholar Jennifer Nuzzo says the Covid-19 vaccines are doing their job and not everyone may need a booster shot. She's on "Bloomberg Surveillance." The Bloomberg School of Public...
Bloomberg
Barrick 'excited’ by gold industry project opportunities
Sep.15 -- Barrick Gold CEO Mark Bristow said he is “excited” by some of the new project opportunities in the gold industry. Speaking to Taylor Riggs and Amanda Lang on Bloomberg Markets, Bristow said he sees gold prices as well...
Bloomberg
Why America Lags the World on Lifting Covid Restrictions
Johns Hopkins Bloomberg School of Public Health Professor Chris Beyrer discusses countries lifting Covid restrictions, regional recovery from omicron in the U.S., and China's vulnerability to Covid-19 as the Olympic games begin. The...
Bloomberg
Goldman Sachs' Tilton on Asia's Economic Week Ahead
Sep.06 -- Goldman Sachs Chief APAC Economist Andrew Tilton, discusses the challenges facing central banks as delta cases continue to surge. He also discusses what he is focused on in the week ahead in Asia. Tilton speaks with Haidi...
Bloomberg
J&J Warning to Add to U.S. Vaccine Hesitancy: Johns Hopkins
Dr. Amesh Adalja, Johns Hopkins Center for Health Security senior scholar, discusses the warning added to Johnson & Johnson���s Covid-19 vaccine and the potential need for a third vaccine booster dose. The Johns Hopkins Bloomberg School...